Cure My Disease

Don't miss your cure!

 Log in / Sign up

New combo pill aims to tackle diabetes and hypertension at once

NCT ID NCT06647745

Recruiting now Disease control Sponsor: THPharm Corp. Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 26, 2026

Summary

This Phase 3 trial tests whether taking dapagliflozin and telmisartan together works better than either drug alone for people with type 2 diabetes and high blood pressure. About 221 adults will receive either the combo or a single drug for 12 weeks. Researchers will measure changes in blood sugar and blood pressure to see if the combination is more effective and safe.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
dapagliflozin and telmisartan
What this could lead to
If successful, this combination could offer a more effective, single-pill option to control both blood sugar and blood pressure in people with type 2 diabetes and hypertension.
What could go wrong
This is a Phase 3 trial, but results may not apply to everyone. Side effects from the drugs (e.g., dehydration, low blood pressure) are possible. The combo may not prove superior to taking each drug alone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESSENTIAL HYPERTENSION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

essential hypertension hypertensive disorder type 2 diabetes mellitus

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HYPERTENSION TYPE 2 DIABETES

Contacts and locations

Study contacts

  • Contact

    Email: •••••@•••••

Locations

  • Thammasat University Hospital

    NOT_YET_RECRUITING

    Pathum Thani, Changwat Pathum Thani, 12120, Thailand

  • The Catholic University of Korea, Yeouido ST. Mary's Hospital

    RECRUITING

    Seoul, 07345, South Korea

More trials for these conditions

Other studies related to the condition(s) this trial covers.